Literature DB >> 16827871

Expanding the donor kidney pool: utility of renal allografts procured in a setting of uncontrolled cardiac death.

S Gagandeep1, L Matsuoka, R Mateo, Y W Cho, Y Genyk, L Sher, J Cicciarelli, S Aswad, N Jabbour, R Selby.   

Abstract

The chronic shortage of deceased kidney donors has led to increased utilization of donation after cardiac death (DCD) kidneys, the majority of which are procured in a controlled setting. The objective of this study is to evaluate transplantation outcomes from uncontrolled DCD (uDCD) donors and evaluate their utility as a source of donor kidneys. From January 1995 to December 2004, 75,865 kidney-alone transplants from donation after brain death (DBD) donors and 2136 transplants from DCD donors were reported to the United Network for Organ Sharing. Among the DCD transplants, 1814 were from controlled and 216 from uncontrolled DCD donors. The log-rank test was used to compare survival curves. The incidence of delayed graft function in controlled DCD (cDCD) was 42% and in uDCD kidneys was 51%, compared to only 24% in kidneys from DBD donors (p < 0.001). The overall graft and patient survival of DCD donors was similar to that of DBD donor kidneys (p = 0.66; p = 0.88). Despite longer donor warm and cold ischemic times, overall graft and patient survival of uDCD donors was comparable to that of cDCD donors (p = 0.65, p = 0.99). Concerted efforts should be focused on procurement of uDCD donors, which can provide another source of quality deceased donor kidneys.

Entities:  

Mesh:

Year:  2006        PMID: 16827871     DOI: 10.1111/j.1600-6143.2006.01386.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  9 in total

1.  Transplantation: Pediatric kidney donation after cardiac death.

Authors:  Randall S Sung
Journal:  Nat Rev Nephrol       Date:  2010-07       Impact factor: 28.314

Review 2.  Kidney donation after cardiac death.

Authors:  Jacob A Akoh
Journal:  World J Nephrol       Date:  2012-06-06

3.  Comparison of normothermic and hypothermic perfusion in porcine kidneys donated after cardiac death.

Authors:  Matthew F Blum; Qiang Liu; Basem Soliman; Paul Dreher; Toshihiro Okamoto; Emilio D Poggio; David A Goldfarb; William M Baldwin; Cristiano Quintini
Journal:  J Surg Res       Date:  2017-04-20       Impact factor: 2.192

4.  Ethical and Logistical Issues Raised by the Advanced Donation Program "Pay It Forward" Scheme.

Authors:  Lainie Friedman Ross; James R Rodrigue; Robert M Veatch
Journal:  J Med Philos       Date:  2017-10-01

5.  Expanding the use of expanded criteria donors in kidney transplantation.

Authors:  Luciana Assis-Borba; Marina P Cristelli; Mayara I Paula; Marcelo F Franco; Helio Tedesco-Silva; Jose O Medina-Pestana
Journal:  Int Urol Nephrol       Date:  2014-03-28       Impact factor: 2.370

6.  Protocols for uncontrolled donation after circulatory death: a systematic review of international guidelines, practices and transplant outcomes.

Authors:  Iván Ortega-Deballon; Laura Hornby; Sam D Shemie
Journal:  Crit Care       Date:  2015-06-24       Impact factor: 9.097

7.  Usefulness of morphometric image analysis with Sirius Red to assess interstitial fibrosis after renal transplantation from uncontrolled circulatory death donors.

Authors:  Myriam Dao; Christelle Pouliquen; Hélène François; Sophie Ferlicot; Alyette Duquesne; Katia Posseme; Charlotte Mussini; Antoine Durrbach; Catherine Guettier
Journal:  Sci Rep       Date:  2020-04-23       Impact factor: 4.379

8.  Uncontrolled donors with controlled reperfusion after sixty minutes of asystole: a novel reliable resource for kidney transplantation.

Authors:  Oleg N Reznik; Andrei E Skvortsov; Alexander O Reznik; Alexey N Ananyev; Alexey P Tutin; Denis O Kuzmin; Sergey F Bagnenko
Journal:  PLoS One       Date:  2013-05-30       Impact factor: 3.240

Review 9.  Ischemia-Reperfusion Injury Reduces Long Term Renal Graft Survival: Mechanism and Beyond.

Authors:  Hailin Zhao; Azeem Alam; Aurelie Pac Soo; Andrew J T George; Daqing Ma
Journal:  EBioMedicine       Date:  2018-02-02       Impact factor: 8.143

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.